IFNA17 and acute respiratory distress syndrome: During SARS-CoV-2 infection, two phases can be observed: 1) an early phase with weak IFNα/IFNβ production and limited antiviral responses and 2) an excessive inflammatory immune response which can give rise to cytokine storms or acute respiratory distress syndrome.